Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

March 31, 2012

Conditions
Parkinson's Disease
Interventions
DRUG

Tigan®

Oral capsule, 300mg three times daily

DRUG

Placebo

Oral capsule, three times daily

Trial Locations (27)

11725

Parkinson's Disease and Movement Disorders Center of Long Island, Commack

12401

Kingston Neurological Associates, Kingston

21075

Parkinson's & Movements Disorders Center of Maryland, Elkridge

23456

Sentara Neurological Associates, Virginia Beach

27607

Raleigh Neurology Associates, Raleigh

30322

Emory University, Atlanta

32174

Neurology Associates of Ormond Beach, Ormond Beach

32209

University of Florida at Jacksonville, Jacksonville

32608

Neurology at Shands Medical Center, Gainesville

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

33606

USF Parkinson's Disease and Movement Disorders Center of Excellence, Tampa

33701

Suncoast Neuroscience Associates, Inc., St. Petersburg

33952

Charlotte Neurological Services, Port Charlotte

44195

Neurological Institute, Cleveland Clinic, Cleveland

48025

Quest Research Institute, Bingham Farms

48034

Henry Ford Health System - Franklin Point, Southfield

50309

Iowa Health Physicians, Des Moines

60026

NorthShore University Health System, Glenview

75231

Neurology Specialist of Dallas P.A, Dallas

75701

East Texas Medical Center, Tyler

77030

Parkinson's Disease and Movement Disorders Center, Baylor College of Medicine, Houston

78258

Coastal Neurological Medical Group Inc., La Jolla

Neurology Associates, P.A., San Antonio

85013

Barrow Neurological Movement Disorder Clinic, Phoenix

85259

Mayo Clinic, Scottsdale

91335

Neurosearch, Inc., Reseda

93003

Neurosearch II, Inc., Ventura

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

INC Research Limited

INDUSTRY

lead

Ipsen

INDUSTRY